课题基金 / 基金详情

PDGFRbeta signaling in craniofacial development.

PDGFRbeta signaling in craniofacial development.
颅面发育中的 PDGFRbeta 信号传导。
批准号:
9091493
负责人:
Katherine Ann Fantauzzo
金额:
$3.8万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2016-09-30

项目摘要

项目成果

Katherine Ann Fantauzzo的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):颅面发育是一个复杂的形态发生过程,其中断导致人类出生缺陷非常普遍。通过血小板衍生生长因子受体α(PDGFRα)的信号传导在颅面发育中起着关键作用;该基因的突变小鼠模型显示出表型,如面部裂开、表皮下起泡和面部老化。虽然该家族中的另一种受体酪氨酸激酶PDGFRβ在颅面发育中没有确定的作用,但文献中的有限证据表明,这两种受体可能能够形成具有与同二聚体受体复合物不同性质的功能性异二聚体。我们的初步体外研究表明,PDGFRα和PDGFRβ在原代小鼠胚胎腭间充质(MEPM)细胞中表达,并能够形成具有激活下游信号通路能力的功能性异源二聚体。进一步的初步体内分析表明,这两种受体相互作用的神经嵴细胞谱系在颅面发育过程中,双纯合子突变胚胎表现出明显的面部裂表型与表皮下起泡,这是更严重的比观察到的任何一个单一的突变胚胎。本申请的目的是探索PDGFRβ在颅面发育中的作用,长期目标是鉴定在中线发育期间在该受体下游发挥作用的新型效应分子,并表征其在面部裂隙和表皮下水泡病因学中的作用。首先,同源重组敲入方法将用于产生PdgfrbmCherry无效报告等位基因.记者表情将 用荧光体视显微镜对颅面结构进行整体分析,用免疫荧光分析对冠状冰冻切片进行分析。其次,将分别通过蛋白质印迹、BrdU掺入试验、细胞生长曲线和Transwell试验,评估PDGFRβ同二聚体与PDGFRα/β异二聚体活化下游的信号传导途径活化、增殖、存活和迁移。最后,PDGFRα和PDGFRβ的相互作用将在体内颅面发育期间进行表征,方法是采用两种基因的条件等位基因以及Wnt 1-Cre驱动因子,以靶向神经嵴消融。通过形态学、组织学和标记物表达分析,将复合突变小鼠的表型与单一纯合突变胚胎的表型进行比较。本申请中概述的研究策略将利用PDGF信号通路可用的大量试剂,并产生重要的新工具,以探索颅面生物学的新方面。本文提出的创新性研究将探索PDGFRβ在面部间充质中的表达,并确定颅面发育过程中PDGFRβ同源二聚体和PDGFRα/β异源二聚体激活下游诱导的信号通路和细胞过程,最终为预防颅面出生缺陷提供新的治疗方向。
英文摘要
DESCRIPTION (provided by applicant): Craniofacial development is a complex morphogenic process, disruptions in which result in highly prevalent birth defects in humans. Signaling through platelet-derived growth factor receptor alpha (PDGFRα) plays a critical role in craniofacial development; mutant mouse models of the gene display phenotypes such as facial clefting, subepidermal blebbing and facial hemorrhaging. While the other receptor tyrosine kinase in the family, PDGFRβ, does not have an established role in craniofacial development, limited evidence from the literature indicates that the two receptors may be able to form functional heterodimers with distinct properties from homodimeric receptor complexes. Our preliminary in vitro studies reveal that PDGFRα and PDGFRβ are expressed in primary mouse embryonic palatal mesenchyme (MEPM) cells and are capable of forming functional heterodimers with the capacity to activate downstream signaling pathways. Further preliminary in vivo analyses demonstrate that the two receptors interact in the neural crest cell lineage during craniofacial development, as double homozygous mutant embryos exhibit an overt facial clefting phenotype with subepidermal blebbing that is more severe than that observed in either single mutant embryo. The aim of this application is to explore the role of PDGFRβ in craniofacial development, with a long-term goal of identifying novel effector molecules operating downstream of this receptor during midline development and characterizing their role in the etiology of facial clefting and subepidermal blebbing. First, a homologous recombination knock- in approach will be used to generate a PdgfrbmCherry null reporter allele. Reporter expression will be analyzed in craniofacial structures in whole mount using a fluorescent stereomicroscope and in coronal frozen sections by immunofluorescence analysis. Second, the activation of signaling pathways, proliferation, survival and migration will be assessed downstream of PDGFRβ homodimer versus PDGFRα/β heterodimer activation by Western blotting, BrdU incorporation assays, cell growth curves and Transwell assays, respectively. Finally, the interaction of PDGFRα and PDGFRβ will be characterized during craniofacial development in vivo, by employing conditional alleles for both genes together with a Wnt1-Cre driver to target ablation in the neural crest. The phenotypes of compound mutant mice will be compared to those of single homozygous mutant embryos by morphological, histological and marker expression analyses. The research strategy outlined in this application will take advantage of the vast array of reagents available for the PDGF signaling pathway, as well as generate vital new tools, to explore novel aspects of craniofacial biology. The innovative studies proposed here will explore the expression of PDGFRβ in the facial mesenchyme and identify the signaling pathways and cellular processes induced downstream of PDGFRβ homodimer and PDGFRα/β heterodimer activation during craniofacial development, ultimately providing new therapeutic directions aimed at the prevention of craniofacial birth defects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Srsf3-mediated alternative RNA splicing in craniofacial development
  • 批准号:
    10650417
  • 项目类别:
  • 资助金额:
    $48.61万
  • 财政年份:
    2022
  • 负责人:
    Katherine Ann Fantauzzo
  • 依托单位:
Srsf3-mediated alternative RNA splicing in craniofacial development
  • 批准号:
    10518288
  • 项目类别:
  • 资助金额:
    $49.38万
  • 财政年份:
    2022
  • 负责人:
    Katherine Ann Fantauzzo
  • 依托单位:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
  • 批准号:
    10361222
  • 项目类别:
  • 资助金额:
    $12.53万
  • 财政年份:
    2019
  • 负责人:
    Katherine Ann Fantauzzo
  • 依托单位:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
  • 批准号:
    10576282
  • 项目类别:
  • 资助金额:
    $12.53万
  • 财政年份:
    2019
  • 负责人:
    Katherine Ann Fantauzzo
  • 依托单位:
海外基金